NEW YORK (GenomeWeb News) – Caliper Life Sciences plans to consolidate its California operations in order to lower its facility costs and to increase the productivity of its research and development expenses, the company said today.
 
The move involves laying off around 13 employees and moving around 33 others who are principally engaged in R&D activities from its Mountain View facilities to those in Alameda.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.